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Effect of Gestational Diabetes on Purkinje and Granule 
Cells Distribution of the Rat Cerebellum in 21 and 28 days of 
Postnatal Life
Introduction: Diabetes mellitus is associated with nervous system alterations in both human 
and animal models. This study was done to determine the effect of gestational diabetes on the 
Purkinje and granular cells in the cerebellum of rat offspring.
Methods: 10 Wistar rats Dams were randomly allocated in control and diabetic group. The 
experimental group received 40 mg/kg/body weight of streptozotocin (STZ) at the first day of 
gestation and control groups received saline injection intraperitoneally (IP). Six male offsprings 
of gestational diabetic mothers and control dams, at the 21, 28 postnatal days were randomly 
scarified and coronal sections of cerebellum (6 micrometer) serially collected. The neurons were 
stained with cresyl violet. 
Results: The Purkinje cells density in the apex and depth of cerebellum in P21, in the experimental 
group was reduced  23% and 15%  in comparison with the control group (P<0.001). The granular 
cells density in the experimental group was reduced 19.58% and 18.3% in comparison with 
the controls (P<0.001). The Purkinje cells density of cerebellum in P28, in the diabetic group 
reduced to 22.12% and 12.62% in comparison with the control group (P<0.001). The granular 
cells density in the diabetic group reduced 17.14% and 16.12% in comparison with the control 
group (P<0.001).
Discussion: The Purkinje and granular cells significantly reduced in gestational diabetes rat 
offspring.
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1. Introduction
iabetes mellitus characterized by hypergly-
cemia, altered metabolism of lipids, carbo-
hydrates and proteins (Yurii, Lebeda, Orlo-
vskya, &Nikonenkoa, 2008).
Type I or insulin dependent, type II or insulin indepen-
dent and Gestational diabetes are three general classifica-
tions of diabetes mellitus (Persaud, 2007). Diabetes mel-
litus is associated with peripheral neuropathy, and central 
nervous system alterations in both human and animal 
models of the disease (Biessels, Heide, Kamal, Bleys & 
Gispen, 2002). 
Dysfunctions of the central nervous system include ab-
normal expression of hypothalamic neuropeptides, hip-
pocampal astrogliosis (Saraviaet al., 2002), decreased 
hippocampal synaptic plasticity, neurotoxicity and 
changes in glutamate neurotransmission (Gardoniet al., 
2002). Diabetic patients are prone to moderate alterations 
in memory and learning.
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Gestational diabetes mellitus (GDM) defined as impaired 
glucose tolerance affects approximately 4% of all preg-
nant women who have never before had diabetes, but who 
do have high blood glucose levels during pregnancy (Per-
saud, 2007).
The cerebellum has long been recognized as the primary 
center of motor coordination in the central nervous system 
(Gardoni et al., 2002; Ahmadpour & Haghir, 2011). Re-
cent studies in humans have also implicated the cerebel-
lum in cognitive processing and sensory discrimination in 
medical conditions as diverse as pervasive developmental 
disorders, autism, and cerebellar vascular injuries (Allen, 
Yaqoob, & Harwood, 2005).
Disorder and disagreement in cerebellar structure is re-
ported due to type 1 diabetes mellitus (Hernandez-Fon-
seca et al., 2009). Also, Min et al reported a decrease of 
neuron and thickness of cortex and white matter of cer-
ebellum due to maternal diabetes in neonatal rats (Min et 
al., 2005).
Follow-up studies concerning the adverse effects of dia-
betic pregnancy on the developing brain have revealed 
neurobehavioral deficits in both sensory-cognitive and 
psychomotor functions, including  altered auditory recog-
nition memory processing at birth (Siddappa et al.,2004), 
reduce visual and memory performance at 8 and 12 
months (DeBoer, Wewerka, Bauer, Georgieff, & Nelson, 
2005), poorer performance on tests of general develop-
ment in infants and toddlers and inferior performance in 
elementary school children (Ornoy,2005). 
While motor delay may be a sign of mild, nonspecific 
brain damage, the abnormalities in memory processing 
suggest alterations in hippocampal development and func-
tion (Nelson et al., 2000).
Although previous studies have shown  the adverse effects 
of pre-gestational maternal diabetes on CNS including 
hippocampus, hypothalamus, cerebellum and cerebrum 
(Beauquis, Roig, Homo-Delarche, De Nicola, & Saravia, 
2006; Ahmadpour & Haghir, 2011) but there is no study 
about the effect of gestational diabetes on neuronal devel-
opment of cerebellum. Therefore, this experimental study 
was design to assess the effect of gestational diabetes on 
the cerebellum at postnatal 21 and 28 day of Wistar rats.
2. Methods
2.1. Animals
This experimental study was performed at the Gorgan 
faculty of Medicine, Golestan University of medical sci-
ences, Gorgan, Iran. Guidelines on the care and use of 
laboratory animals and approval of the ethic committee 
of Golestan University of medical sciences were obtained 
before study.
Experimental animals. Wistar rats, weighing 180-220 
grams (12 weeks old) were used in this study. The animals 
were maintained in a climate-controlled room under a 12-
hour alternating light/dark cycle, 20 °C to 25°C tempera-
ture, and 50% to 55% relative humidity. Dry food pellets 
and water were provided ad libitum.
2.2 Drugs
Streptozotocin (STZ) (Sigma, St. Louis, MO, USA) was 
dissolved in sterile saline solution (0.85%) to give 40 mg/
kg dose intraperitoneally inject to female rats. 
Histology
Animal groups and treatment: After 2 weeks of acclima-
tion to the diet and the environment, female Wistar rats 
were placed with a proven breeder male overnight for 
breeding. Vaginal smears were done the next morning to 
check for the presence of sperm. Once sperm was detected 
that day was assigned as gestational day 1(GD). On day 1 
of gestation, pregnant females were randomly divided into 
two control and diabetic groups. 
Five female rats in diabetic group receiving 40 mg/kg/
body weight of streptozotocin (STZ) and control groups 
(five rats) receiving an equivalent volume normal saline 
injection intraperitoneally (IP). Blood was sampled from 
the tail at 1 week after STZ injection. The dams with 
blood glucose level 120-250 mg/dl were considered as 
gestational diabetes (GDM). The pregnancy of dams was 
terminated physiologically.
Totally, six male offspring of gestational diabetic moth-
ers and control mothers at postnatal 21 and 28 day (P21, 
P28) were randomly selected and were scarified. For light 
microscope preparations, cerebellum was fixed in 10% 
neutral-buffered formalin for histological procedure. The 
coronal sections (6 micrometer) were serially collected 
from bregma -9.96 mm to -11.88 mm of cerebellum 
(Paxinos& Watson, 1998). The sections were stained with 
cresyl violet. 
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Blood glucose measurements: Blood glucose level of 
mothers (before mating and after STZ injection) and 
offspring was obtained via tail vein and was estimated 
with a glucometer (ACCU-CHEK® Active Glucometer, 
Roche Diagnostics, Mann-heim, Germany). 
Morphometric analysis:
At postnatal 21 and 28 day, the size (transvers diameter) 
of cerebellum was measured using the digital vernier 
caliper in the experimental and control groups.
In each sample, ten similar sections of anterior lobes of 
cerebellum were selected and images of five separate 
fields in the apex of cerebellar lobules and five separate 
fields in the depth of cerebellar lobules were captured by 
Olympus BX 51 microscope and DP12 digital camera 
attached to OLYSIA autobio report software (Olympus 
Optical, Co. LTD, Tokyo, Japan). 
The morphometric analysis of cerebellum including den-
sities of Purkinje cell, the number of Purkinje cells per 
1000 µm length of Purkinje cell line, diameter and area 
of the Purkinje cells were measured from high magnifi-
cation (1000x). Also densities of granular cells (the num-
ber of the granular cells/ 10000 µm2 area of granular cell 
layer) and the thickness of cerebellar cortex including 
thickness of molecular layer (ML), Purkinje cell layer 
(PCL) and granular cell layer (GL) were measured from 
low magnification (20x objective) (Fig 1A and 1B).
Statistical analysis
Morphometric data is expressed as the mean ± SEM and 
analyzed by the Student’s “t” test using SPSS 16.5 soft-
ware. P<0.05 was considered significant. 
Insemination Day Day 21 Day 28
Control GDM Control GDM Control GDM
97.7±2.3 97.35±2.2 97.5±2.5 141.2±3* 97.8±2.0 155.5±3.5*
Table 1.   Maternal blood glucose level (mg/dl; Mean ± SEM) on the  insemination day, 21 and 28 day after delivery in control 
and streptozotocin-exposed groups.
Results are expressed as Mean ±SEM of the mean (*P < 0.001, n=5)
Characteristics 
Control
(P21)
GD
(P21)
Control (P28)
GD
(P28)
Apex
PC density 
(PC Number /10000 μm length of PCL) 
10.5±0.6 8.08±0.5 10.8±0.8 8.41±0.7
area of PCs (μm2) 155.43±7.2 219.75±9.1 145.54±7.7 175.8±8.7
diameter of PCs (μm) 12.44±0.3 15.61±0.5 12.63±0.4 14.18±0.5
GC density at apex
(GC Number /10000 μm2 area of GCL)
26.56±0.6 22.21±0.6 25.72±0.7 21.31±0.6
Depth
PC density 
(PC Number /10000 μm length of PCL)
11.62±0.7 9.86±0.2 12.92±0.2 11.29±0.2
area of PCs (μm2) 119.85±5 186.2±6.6 119.48±9.4 148.62±7
diameter of PCs (μm) 12.75±0.3 16.19±0.6 12.74±0.3 14.46±0.3
GC density 
(GC Number /10000 μm2 area of GCL)
29.16±0.6 24.65±0.5 30.08±0.8 25.23±1.3
Table 2. The quantitative characteristics of the Purkinje cells of cerebellum in postnatal day 21 and 28 of gestational 
diabetes mellitus (GDM) and control mothers in Wistar rat.
Results are expressed as Mean ±SE of the mean, P<0.05 versus control, n=6
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3. Results
Blood glucose concentrations
The mean ± SEM of blood glucose concentrations be-
fore mating and in day 21 and 28 after delivery of gesta-
tional diabetic and control mothers is depicted in Table 1. 
Blood glucose level significantly increased in gestational 
diabetic dams after STZ injection compared to controls 
(P < 0.05).  
Morphometric results
The morphometric findings are depicted in Table 2, 
3 and Fig 2 (apex and depth).
Purkinje cells density:
The Purkinje cells density of apex and depth(PC number 
/10000 μm length of PCL)of cerebellum in P21, in the 
experimental group reduced 23% and 15% in compari-
son with the control group (apex: 8.08±0.5 vs 10.5±0.6, 
depth: 9.86±0.61 vs 11.62±0.72, P<0.007). 
The Purkinje cells density of apex and depth of cerebel-
lum in P28, in the experimental group reduced 22.12% 
and 12.62%  in comparison with the control group 
(apex: 8.41±0.72 vs10.80±0.87, depth: 11.29±0.27 
vs12.92±0.29, P<0.001).
The mean area and diameter of the Purkinje cells in the 
treated group was significantly larger than the control 
group (Table 1). 
Granular cells density:
In P21, the granular cells density of apex and depth(GC 
number /10000 μm2 area of GCL) in the experimental 
group reduced 19.58% and 18.3% in comparison with 
the control group (apex: 22.21±0.6 vs 26.56±0.6, depth: 
24.65±0.5 vs 29.16±0.6, P<0.001). In P28, The granu-
lar cells density of apex and depth in the experimental 
group reduced 17.14% and 16.12% in comparison with 
the control group (apex: 21.31±0.6 vs 25.72±0.7, depth: 
25.23±1.37 vs 30.08±0.82, P<0.001).
The thickness of the cerebellar cortex layer: 
The thickness of molecular, Purkinje and granular lay-
ers at the apex of cerebellar lobules of the experimental 
group significantly reduced in comparison with the con-
trol group (P<0.05).  
The thickness of molecular layer at the depth of cerebel-
lar lobule in experimental group (P21) reduced in com-
parison with the controls (157.94±6.10 vs 185.42±9.44), 
the Purkinje layer in experimental group reduced com-
pared to the control group (20.80±0.32 vs 23.33±0.39), 
and granular layer significantly reduced in comparison 
with the control group (114.18±2.53, 135.11±11.42). 
The thickness of molecular layer at the depth of cerebel-
lum in experimental group (P28) reduced in comparison 
with the control group (166.85±5.79 vs 194.49±4.21), the 
Purkinje layer in experimental group reduced in compar-
ison with the control group (21.32±0.55 vs 23.77±0.62), 
and granular layer significantly reduced in comparison 
with the control group (118.46±4.13, 138.39±7.98, 
P<0.05).
Layer
Control
P21 P28
GD P Control GD P
apex
ML 99.77±4.6 89.37±2.8 .05 117.73±6.3 110.9±3.4 .05
PCL 22.25±1.1 19.56±0.5 .02 22.61±0.9 19.97±0.6 .03
GL 215.86±8.8 196.6±2.9 .01 210.11±4.4 176.15±6.0 .01
depth
ML 185.41±9.4 157.94±6.1 .01 194.48±4.2 166.84±5.7 .003
PCL 23.33±0.3 20.8±0.3 .001 23.77±0.6 21.32±0.5 .01
GL 135.10±11.4 114.17±2.5 .02 138.38±7.9 118.45±4.1 .02
Table 3. The thickness of the various layers of cerebellar cortex (μm) in postnatal day 21 and 28 (P21, P28) of gestational diabe-
tes (GDM) mothers and control mothers in Wistar rat
ML: molecular layer, PCL: Purkinje cell layer, GL: granule cell layer. Results are expressed as Mean ±SE of the mean, P<0.05 
versus control, n=6
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The transvers diameter of cerebellum in the experimental 
group (P21) significantly reduced in comparison with the 
control group (12.53±0.43vs 11.10±0.05 mm) P<0.05).
The transvers diameter of cerebellum in the experimental 
group (P28) significantly reduced in comparison with the 
control group (12.82±0.67vs 11.23±0.03 mm) P<0.05).
4. Discussion
The present study demonstrated that gestational diabetes 
produces a significant reduction in the density of the Pur-
kinje and Granular cells and several layers of cerebellum 
in the postnatal day 21 and 28 of Wistar rats.
Previous studies have shown reducing neuronal cells 
density in animals with type 1 diabetes mellitus (Beau-
quiset al., 2006; Ahmadpour & Haghir, 2011). Also 
Hernandez-Fonseca et al., study has shown that STZ- 
induced diabetes increased apoptosis in pyramidal neu-
rons in cortex and cerebellar Purkinje cells in adults’ rats 
(Hernandez-Fonseca et al., 2009).
Indeed, Khaksar et al. study has shown the adverse ef-
fects of maternal diabetes on reduction of neuron and 
thickness of cortex and white matter of cerebellum in 
neonatal rats (Khaksar, Jelodar & Hematian, 2010).
In spite of several studies regarding the effects of dia-
betes I and II on CNS including cerebellum, there is no 
investigation about the effect of gestational diabetes on 
cerebellar neurons in 21 and 28 day offspring.
Our animal model study demonstrated that gestational 
diabetes similar to type I and II diabetes mellitus, estab-
lished a significant reduction in the cerebellar Purkinje 
and granular cells in the postnatal 21 and 28 day of Wi-
star rats.
Figure 1. Histological section of cerebellum cortex postnatal day 28 (P28) Wistar rat in A: control and B: case group (20× mag-
nification, scale bar: 100 μm). C: control and D: case group (1000× magnification, scale bar: 20 μm). Section stained with cresyl 
violet. ML: molecular layer, PCL: Purkinje cell layer, GL: granule cell layer, WM: white matter, black arrow: Purkinje cell, white 
arrow: granular cell.
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The reduction of Purkinje cell density of cerebellum can 
be due to program cell death or block of neurogenesis in 
CNS, including cerebellum (Hernandez-Fonseca et al., 
2009). Hyperglycemia could induce cellular death by en-
hancing tissue acidosis (DeBoeret al., 2005).
Diabetes mellitus, regardless of its type, is associated 
with hyperglycemia. Several possible mechanisms are 
explained about cerebral alterations including neuronal 
loss of cerebellum due to hyperglycemia. 
Diabetes mellitus is associated with increased oxidative 
stress in central nervous system (Grilloet al., 2003).The 
polyol pathway is activated during hyperglycemia and 
leads to consumption of NADPH and depletion of glu-
tathione, which in turn lowers the threshold for intracel-
lular oxidative injury (Klein & Waxman, 2003).
CNS complications of diabetes mellitus could be mediat-
ed through excessive free radicals generation (Okouchi, 
Okayama, & Aw, 2005; Ahmadpour & Haghir, 2011). 
These radicals contribute to increase neuronal death by 
oxidizing proteins, damaging DNA, and inducing the 
lipoperoxidation of cellular membranes (Hawkins & Da-
vies, 2001).
Hyperglycemia may cause brain acidosis and dehydra-
tion, both involved in diminished cerebral blood flow 
and ischemia (Chen & Goeddel, 2002; DeBoer et al., 
2005). Ischemia-related edema involves stimulation of 
brain Na-K-Cl cotransporter system facilitating edema 
formation and swelling of endothelial cells (Gardoni et 
al., 2002).
Also, in other cellular responses increase formation of 
advanced glycosylation end-products damages endothe-
lial cells, therefore it is contributed to vascular damage 
indeed, during hyperglycemia. Diacylglycerol activa-
tion of protein kinase C has negative effects on cerebral 
blood flow and vascular permeability (Klein & Waxman, 
2003).
Indeed, Several studies have shown that offspring of dia-
betic mothers have lower arachidonic acid (AA:20:4n-6) 
Figure 2. The mean number of Purkinje cells in apex and depth of cerebellum of 
postnatal day 21 and 28 of offspring in gestational diabetes mellitus (GDM) and 
control dams in Wistar rats. The cells were expressed as the number of Purkinje cells 
per 10000 μm2, (results are means± SEM, *Compared with controls P<0.05, n=6).
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and docosahexaenoic acid (DHA:22:6n-3) in cord blood 
(Min et al., 2005) .
Arachidonic Acid metabolite and prostaglandin E2 plays 
an important role in neurogenesis. Zhao et al (2009) have 
reported that maternal arachidonic acid supplementation 
improves neurodevelopment in young adult offspring 
from rat dams with and without diabetes (Zhao, Del Bi-
gio &Weiler, 2009). 
Also, other possible mechanism regarding program cell 
deaths in diabetes mellitus (Allen et al., 2005; Lechuga-
Sancho et al., 2006; Hernandez-Fonseca et al., 2009) can 
be due to decrease insulin or insulin-like growth factor 
signaling or an increase in cytokines such as TNFa (Chen 
&Goeddel,2002). 
Moreover, insulin-like growth factor has a neuroprotec-
tive and anti-apoptotic effect and down regulation of ex-
pression of insulin-like growth factor and its receptor in 
diabetes might also lead to neuronal loss (Romero, Liu, 
Asnaghi, Kern, & Lorenzi, 2002).
Furthermore, several studies have shown that the dam-
age to both presynaptic and postsynaptic structures in the 
hippocampus in diabetes from hyperglycaemia induced 
alterations in the handling and homoeostasis of intracel-
lular calcium concentrations (Magarinos & McEwen, 
2000). 
Down regulation of nitric oxide synthase (NOS), mRNA 
and protein concentrations are the main factors in active 
response of cells due to hyperglycemia. These changes 
are shown in hippocampal neurons (Reagan & McEwen, 
2002). 
The increasing size of cerebellum in offsprings in ex-
perimental group compared to controls can indicate the 
edema in cerebellum due to gestational diabetes in dams.
 This study showed the uncontrolled gestational diabetes 
inducesreduction ofthe Purkinje neurons in offspring. 
Further studies are required for exploring the exact 
mechanism of CNS complications of gestational diabe-
tes mellitus. 
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